Warburg Pincus related stories
All articles and analysis
KKR, Warburg, Cinven Eye Bids For PRAKohlberg Kravis Roberts & Co, Warburg Pincus LLC and Cinven Ltd are weighing bids for PRA International, a clinical research group, which is for sale and could fetch as much as $1.3 billion, several people familiar with the matter told sister news service Reuters.
- KKR, Warburg, Cinven Eye Bids for Clinical Trial Firm PRA -Sources
Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are weighing bids for PRA International, a clinical research group, which is for sale and could fetch as much as $1.3 billion, sources told Reuters.
Ten Hot Stories: VC Returns Improve a Bit, Better Place Goes Belly Up and LPs Talk Straight to VCsTrending on peHUB this week: VC returns, straight-talking LPs, tech M&A, Better Place, NEA, Valeant, Bausch & Lomb, Mary Meeker, Kleiner Perkins, Andreessen Horowitz, Yahoo, Tumblr, Warburg Pincus, Adeo Ressi
- Carlyle, Advent, Others in Hunt for HP's MphasiS Stake: Sources
The Carlyle Group LP and Blackstone Group LP as well as Indian outsourcers L&T Infotech and Tech Mahindra Ltd, are lining up bids for Hewlett-Packard Co's $1 billion stake in India's MphasiS Ltd, sources tell Reuters.
- Santander Sells 50 Percent Stake in Asset Management Arm
Spain's biggest bank, Santander, said on Thursday it had reached a deal with U.S. private equity firms Warburg Pincus and General Atlantic LLC to sell them a 50 percent stake in its asset management arm, Reuters reports.
- Warburg Pincus-led Group Places $200 Mln Bet on Vietnam Retail Growth
A consortium led by U.S. buyouts fund Warburg Pincus said on Wednesday it has agreed to buy around 20 percent of the retail unit of Vietnam's Vingroup Joint Stock Co for $200 million, Reuters reports.
- Warburg Exits Primerica
Primerica has agreed to buy back about $154.7 million in stock and warrants from Warburg Pincus. Follow the sale, Warburg Pincus will no longer own Primerica stock. Duluth, Ga.-based Primerica distributes financial products to middle income households in North America.
Warburg to Make Nearly 3x its Money on Bausch & Lomb SaleWarburg Pincus looks like it will nearly triple its investment once it sells Bausch & Lomb to Valeant Pharmaceuticals.
- Valeant Acquires PE-Backed Bausch + Lomb for $8.7B
Montréal-based Valeant Pharmaceuticals International Inc. has agreed to buy eye care specialist Bausch + Lomb Holdings Inc. from U.S. private equity firm Warburg Pincus, which acquired the Rochester, New York-based company in 2007. The agreement, which has been approved by the directors of both companies, provides that Valeant will pay US$8.7 billion in cash, of which around US$4.5 billion will go to Warburg Pincus and other investors, and around US$4.2 billion will be used to repay Bausch + Lomb's debt. The deal is expected to close in the third quarter of 2013.